Physician profile
Steven Craig Brousell
NPI 1679991483
$6,415.19
in general payments reported to CMS, 2019-2025
44 companies · $2,942 in 2025
The $2,942 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,008 · 2023: $1,469 · 2024: $997 · 2025: $2,942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,883 · Consulting Fee: $2,125 · Travel and Lodging: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,882.83 |
| Consulting Fee | $2,125.00 |
| Travel and Lodging | $399.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $1,250.00 | 2025 | Npd Clinical Study |
| Coloplast Corp | $1,003.04 | 2022-2024 | Titan, Porges Coloplast |
| Olympus Winter & Ibe Gmbh | $875.00 | 2025 | Endoeye Flex Deflectable Videoscope |
| Procept Biorobotics Corporation | $327.14 | 2025 | |
| Sumitomo Pharma America, INC. | $288.14 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $257.87 | 2022-2024 | Lumenis Pulse 120h |
| Medtronic, INC. | $243.90 | 2023-2024 | Interstim |
| Richard Wolf Medical Instruments Corp. | $183.61 | 2023 | |
| Palette Life Sciences, INC. | $173.65 | 2022 | |
| Endo Pharmaceuticals INC. | $162.31 | 2022-2024 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $146.68 | 2022-2024 | Prolaris |
| Teleflex LLC | $132.00 | 2022-2025 | Barrigel, Urolift |
| Endo USA, INC. | $125.25 | 2024-2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $114.94 | 2025 | |
| Laborie Medical Technologies Corp. | $96.26 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $94.25 | 2022-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $70.92 | 2023-2024 | Botox |
| Axonics, INC. | $69.99 | 2022-2023 | Axonics |
| Stryker Corporation | $68.12 | 2024-2025 | 1788 |
| Blue Earth Diagnostics | $56.46 | 2022 | |
| Urovant Sciences INC | $53.89 | 2022 | |
| Merck Sharp & Dohme LLC | $53.21 | 2024 | Keytruda, Welireg |
| Bayer Healthcare Pharmaceuticals INC. | $43.67 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $42.66 | 2024-2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $41.55 | 2022-2024 | Lynparza |
| Edap Technomed INC | $41.36 | 2025 | |
| Agiliti Surgical, INC. | $40.44 | 2022-2023 | Sonablate, Trinity |
| Olympus America INC. | $33.54 | 2024-2025 | Itind System |
| Smith+Nephew, INC. | $30.96 | 2024 | Grafix |
| Terumo Medical Corporation | $29.30 | 2025 | Angio-Seal |
| Angiodynamics, INC. | $28.81 | 2025 | Nanoknife |
| 180 Medical, INC. | $25.73 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $23.19 | 2025 | |
| Tolmar, INC. | $20.46 | 2024 | |
| Pfizer INC. | $19.23 | 2023 | |
| Lsi Solutions INC | $18.91 | 2024 | Jnw Urtrac |
| Antares Pharma, INC. | $18.71 | 2023 | Nocdurna, Xyosted, Tlando |
| Sun Pharmaceutical Industries INC. | $18.63 | 2024 | |
| Photocure INC | $18.49 | 2024 | Cysview |
| Ambu INC. | $17.48 | 2024 | |
| Verity Pharmaceuticals INC. | $17.33 | 2025 | Trelstar |
| Baxter Healthcare | $15.89 | 2023 | Floseal |
| Civco Medical Instruments | $13.88 | 2024 | |
| Intuitive Surgical, INC. | $8.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Brousell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.